Edition:
India

Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

60.35USD
14 Dec 2017
Change (% chg)

$-0.22 (-0.36%)
Prev Close
$60.57
Open
$60.61
Day's High
$62.08
Day's Low
$60.34
Volume
763,876
Avg. Vol
724,033
52-wk High
$84.13
52-wk Low
$54.67

Select another date:

Thu, Nov 30 2017

BRIEF-Cordis And Medinol Announce FDA Approval Of EluNIR Drug-Eluting Stent System

* CORDIS AND MEDINOL ANNOUNCE FDA APPROVAL OF THE INNOVATIVE ELUNIR DRUG-ELUTING STENT SYSTEM Source text for Eikon: Further company coverage:

UPDATE 3-Shanghai Pharma buys U.S. Cardinal Health's China business for $557 mln

* Cardinal Health put business up for sale due to rule changes

Shanghai Pharma buys U.S. Cardinal Health's China business for $557 mln

Nov 15 State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc's China business, one of the nation's largest drug distributors, for $557 million.

BRIEF-Cardinal Health to sell its china business to Shanghai Pharma for $1.2 bln‍​

* Cardinal health signs definitive agreement to sell its china business to Shanghai Pharma

BRIEF-Cardinal Health says shareholders re-elected all 11 members to board in preliminary voting ​

* Cardinal Health - ‍based on preliminary results of shareholder voting at co's annual meeting, shareholders re-elected all 11 members to board​ Source text for Eikon: Further company coverage:

CORRECTED-UPDATE 1-Drug distributor Cardinal names Mike Kaufmann as new CEO

Nov 6 U.S. drug distributor Cardinal Health Inc on Monday named its chief financial officer as its next CEO, and reported a lower-than-expected quarterly revenue as it deals with stubbornly low prices for generic drugs.

BRIEF-Cardinal Health Inc outlines leadership succession plan

* Cardinal Health Inc - ‍Jorge Gomez, CFO of Cardinal Health's medical segment, to succeed Kaufmann as chief financial officer​

Drug distributor Cardinal's profit falls 63 pct

Nov 6 U.S. drug distributor Cardinal Health's quarterly profit fell nearly 63 percent, hurt by restructuring costs related to an agreement to directly distribute surgeon gloves in some markets.

BRIEF-Cardinal Health reports Q1 GAAP earnings per share $0.36

* Cardinal Health Inc reports first-quarter results for fiscal year 2018

BRIEF-Galena Biopharma says co and Cardinal Health entered into a settlement relating to product swap agreement​

* Galena Biopharma Inc says on October 12, co and Cardinal Health entered into a settlement relating to product swap agreement​ - SEC filing

Select another date: